Kick off Meeting – Project 2.21

 

 

On 27.11.2019, the team of project 2.21 arranged its official kick-off meeting! The multidisciplinary team of researchers and partners aims to develop and validate new small-molecule based imaging probes targeting the immune checkpoint axis PD-1/PD-L1 using PET. Hence, novel imaging derived biomarkers, which might be of major importance in several cancer entities, are expected within this project, lead by Wolfgang Wadsak in Vienna. Infrastructure as well as scientific expertise are jointly mobilized between CBmed, the scientific partners, Medical University and University of Veterinary Medicine Vienna, and the company partners, ITM (Munich, Germany) and SOFIE Bioscience (Los Angeles, USA).

We want to thank all participants for their active contribution to a very fruitful meeting. We are looking forward to constant progress, an inspiring cooperation and rewarding research outcomes. We’ll keep you updated!

The COMET Center CBmed is funded within COMET – Competence Centers for Excellent Technologies by the Federal Ministry of Transport, Innovation and Technology (BMVIT), the Federal Ministry for Digital and Economic Affairs (BMDW), Land Steiermark (Styrian Business Promotion Agency – SFG) and Land Wien (Vienna Business Agency – WAW). The COMET program is executed by the Austrian Research Promotion Agency (FFG).

CBmed GmbH Center for Biomarker Research in Medicine
Stiftingtalstrasse 5   8010 Graz   Austria   office@cbmed.at   +43 316 385 28801

PRESS CORNER     CONTACT     IMPRINT     PRIVACY

Font Resize
Contrast